A Comprehensive Remission Achieved in a Patient with Leukemia by AB Science
– (CercleFinance.com) – AB Science reported last night a case of ‘complete response’ in one of the patients treated as part of its phase I/II study in acute mylodic leukemia (AML). first cycle of treatment, ie after three consecutive days of treatment with its product AB8939, the company claims to have observed a ‘drastic’ reduction … Read more